USANA Health Sciences management commentary cites weaker Core Nutritional, Rise Wellness sales as drivers of Q3 2026 revenue decline
Bitget2026/11/03 21:24- USANA Health Sciences' management commentary reported third-quarter 2026 sales fell 4% to $206 million as Core Nutritional and Rise Wellness declines outweighed Hiya growth.
- Net loss attributable to USANA narrowed to $5.6 million from $6.5 million; adjusted EBITDA fell 13% to $12.1 million.
- Core Nutritional's operating margin rose to 4.1% from 1.2%, reflecting lower incentive costs, event expenses and employee compensation despite weaker sales.
- Hiya sales increased 2% to $32 million, supported by improving marketing traction and back-to-school demand; increased customer-acquisition spending pressured margins.
- Management corrected second-quarter adjusted EBITDA attributable to USANA to $21.7 million from $27.8 million, removing noncontrolling interests' share of an impairment add-back.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
